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ABSTRACT
PURPOSE: To evaluate renal histological changes and renal function in single kidney rats submitted to renal ischemia-reperfusion and 
to immunosuppression with tacrolimus and mycophenolate-mofetil.
METHODS: Experimental study with 80 Wistar rats distributed into control, Sham and six other groups treated with immunosuppressive 
drugs. Animals undergoing surgery, right nephrectomy and left renal clamping, killed on the 14th day and analyzed for renal histology, 
urea and creatinine.
RESULTS: The group receiving tacrolimus at higher doses (T3) showed renal histological lesions indicative of early nephrotoxicity, 
and significant increase in urea and creatinine. The group M (mycophenolate-mofetil alone) and the group M2 (mycophenolate-mofetil 
combined with half the usual dose of tacrolimus) presented a slight rise in serum urea. The groups using mycophenolate-mofetil alone 
or combined with tacrolimus showed creatinine levels similar to that of the group T3. 
CONCLUSIONS: Histologically, the association of injury by ischemia-reperfusion with the use of tacrolimus or mycophenolate-
mofetil alone demonstrated a higher rate of renal changes typical of early nephrotoxicity. In laboratory, the combination of injury by 
ischemia-reperfusion with tacrolimus at higher doses proved to be nephrotoxic.
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Introduction
Nephropathy or chronic transplant dysfunction (NPC 
Tx) is the leading cause of kidney transplant failure, with 
slowly and progressive deterioration of renal function1. The 
multifactorial pathogenesis of NPC Tx is not yet fully understood, 
and immunological factors, inadequate immunosuppression and 
ischemia-reperfusion time of the organ play an important role in 
the pathophysiology2-4.
Currently, calcineurin inhibitors like tacrolimus and 
cyclosporine are the cornerstones of immunosuppressive therapy. 
These agents are administered combined with antiproliferative 
agents such as mycophenolate-mofetil (MMF), sirolimus and 
azathioprine, with or without steroids. The use of tacrolimus 
associated with MMF is considered the gold standard in most 
transplant programs in the United States5.
Much has been investigated about clinical 
immunosuppression, however, regardless of treatment regimen, 
the immunosuppressant drugs have adverse effects including 
nephrotoxicity5, cardiovascular effects5, diabetes mellitus5, 
cosmetic effects such as hirsutism, gum hyperplasia, alopecia5, and 
changes in the wound healing process6. Nephrotoxicity is a major 
clinical obstacle related to immunosuppression with calcineurin 
inhibitors and is often responsible for the discontinuation 
of treatment5. The histological features of nephrotoxicity 
induced by these drugs are severe interstitial fibrosis, usually in 
stripes, peritubular calcification, arteriolar hyalinosis and focal 
glomerulosclerosis, these changes may result in irreversible 
chronic renal failure in patients undergoing renal transplantation5.
The ischemic time of the transplanted kidney is also 
noteworthy among the risk factors for the development of NPC 
Tx, with studies showing that a longer period of ischemia results in 
release of cytokines, significantly higher vascular and glomerular 
changes associated with increased risk of chronic rejection4.
Injury induced by ischemia and reperfusion has been 
studied as a risk factor for the development of post-transplant 
renal dysfunction. Studies have shown that rats undergoing 
transplantation with longer time of ischemia-reperfusion 
showed significantly higher vascular and glomerular changes 
than animals submitted to transplantation with shorter time of 
ischemia-reperfusion7. Moreover, the authors observed that the 
release of cytokines that accompanies the recovery phase of 
ischemic injury can trigger the cascade of events that would lead 
to chronic rejection7.
In this context, there are few studies assessing the 
simultaneous effect of drug-induced nephrotoxicity and of ischemia 
and reperfusion on post-transplant renal dysfunction8. The model 
used in this trial aimed to evaluate the renal histological changes 
and renal function in Wistar rats with single kidney, subjected to 
ischemia and reperfusion and immunosuppression with tacrolimus 
and MMF.
Methods
This project was approved by the Ethics Committee 
on Animal Experimentation, Biological Sciences Department, 
Federal University of Parana (UFPR) (Certificate 386b). Ethical 
principles for animal experimentation of the Brazilian College of 
Animal Experimentation (COBEA) and the requirements set by 
the Guide for the care and use of experimental animals (Canadian 
Council on Animal Care) were observed.
Technical procedures and postoperative
We used eighty male albino Wistar rats (Rattus norvegicus 
albinus, Rodentia: Mammalia), weighing between 200 and 350 
grams, with free access to water and food. Animals were randomly 
divided into eight groups (Table 1), the control group (C) did 
not undergo surgery. The other seven groups underwent surgery 
following aseptic technique and subsequent treatment (Table 1). 
GROUPS N SURGICAL 
PROCEDURE
TREATMENT
C 10 No 0.9% Saline
SHAM 8 Yes 0.9% Saline
T1 10 Yes Tacrolimus 1mg/kg/day
T2 10 Yes Tacrolimus 0.1mg/kg/day
T3 9 Yes Tacrolimus 10mg/kg/day
M1 10 Yes MMF 20mg/kg/day
MT1 11 Yes MMF 20mg/kg/day 
+Tacrolimus 1mg/kg/day
MT2 10 Yes MMF 20mg/kg/day 
+Tacrolimus 0.5mg/kg/day
TABLE 1 – Groups of animals, surgical procedure and 
post-surgical treatment.
C: control; Tacrolimus: PrografÒ, Janssen-Cilag Ltda.; MMF: Mycophenolate 
mofetil, CellCept®, Genentech Roche.
Thirty minutes before the procedure we used 
intramuscular diazepam as pre-anesthetic at a dose of 5mg/kg. 
Anesthesia was induced by intraperitoneal injection of ketamine 
at 90mg/kg (CetaminÒ - Syntec, Brazil) and xylazine at 10mg/kg 
(XilazinÒ - Syntec, Brazil). The surgical procedure consisted of 
Effects of immunosuppression with tacrolimus and mycophenolate mofetil on renal histology 
and function in single kidney rats submitted to ischemia and reperfusion
Acta Cirúrgica Brasileira - Vol. 30 (2) 2015 - 129
median laparotomy, right nephrectomy and vascular clamping of 
vessels of the pedicle of the left kidney for a period of 20 minutes 
(Figure 1). After this period of warm ischemia, the clamp was 
removed to allow reperfusion. Finally, we performed abdominal 
wall closure in layers.
were investigated: acute tubular necrosis (ATN); acute tubular 
toxicity (ATT), represented by cytoplasmic vacuolation; acute 
vascular toxicity (AVT), represented by arteriolar thrombosis 
(AT), glomerular thrombosis (GT) and intimal edema (IE); chronic 
toxicity (CT), represented by hyaline arteriolopathy (HA), tubular 
atrophy (TA), interstitial fibrosis (IF) and glomerular sclerosis 
(GS), and other less specific findings including inflammatory 
infiltrate (II) and hyaline casts (HC). These parameters were 
graded semi-quantitatively: absent, mild, moderate and severe, 
and transformed into quantitative variables by assigning numerical 
values, from 0 (absent) to 3 (severe). The histological score was 
calculated by averaging the indices of each group.
Statistical analysis
The serum levels of tacrolimus, creatinine and urea 
were analyzed separately, with calculation of mean, median and 
standard deviation of each group. To compare the levels of serum 
tacrolimus and urea, we used the Student’s t-test. For the analysis 
of creatinine values, we applied the nonparametric Mann-Whitney 
test. Histological changes were analyzed using the histological 
score. For comparison between groups, the nonparametric Mann-
Whitney test was used, with significance level of 95% (p <0.05).
Results
Three rats died during the operative procedure, thus were 
excluded from the study. All animals were kept under the same 
care during the experiment, and none had complications or died 
during the postoperative observation.
Biochemical and statistical analysis
Serum levels of tacrolimus were higher according to the 
administered dose; in SHAM and control groups we did not detect 
serum levels of this drug. There was significant difference (p<0.05) 
in serum tacrolimus of the group T3 compared to the other groups 
(Figure 2A). The groups T1 and T2 showed difference in serum 
levels of tacrolimus, but it was not statistically significant (p = 
0.084). The groups MT1 and MT2 had serum levels of tacrolimus 
statistically similar to groups T1 and T2.
Serum levels of urea were significantly greater in groups 
that received drugs compared to SHAM and control groups, except 
for the group M1, which exhibited no significant difference in 
relation to SHAM (M1xSHAM: p=0.19) (Figure 2B). The group 
T3 demonstrated a significant increase of urea in comparison 
FIGURE 1 – Clamping of the left kidney.
On the first day after surgery, the animals received 
intramuscular analgesics (dipyrone) and daily, each group received 
a different type of solution by gavage with suitable technique and 
appropriate size of the tube (Table 1).
Biochemical and histological analysis
The animals were killed on day 14 of the experiment, 
under the same anesthesia protocol. Median thoracotomy was 
performed, followed by cardiac puncture with 25x8 mm needle 
for taking blood sample, and induction of cardiac arrest by 
exsanguination. Samples were analyzed for serum tacrolimus, by 
chemiluminescence, and for urea and creatinine, by enzymatic 
colorimetric method. Subsequently, a new laparotomy was 
carried out with left nephrectomy and preparation of the organ 
for histological analysis. Kidneys were preserved in 10% 
formalin and routinely processed for histology and stained by 
immunohistochemical techniques of hematoxylin-eosin (HE), 
Masson’s trichrome and periodic acid-Schiff (PAS).
The analysis and anatomopathological interpretation 
were performed using light microscopy. The following parameters 
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with all other groups (p<0.05). The group receiving MMF alone 
showed a significantly lower rate of urea increase compared to all 
other groups using tacrolimus, except for the group MT2 (half the 
usual dose of tacrolimus) (MxMT2: p = 0.28 ).
The group in which MMF was used alone and those groups in 
which MMF was combined with tacrolimus showed serum 
levels of creatinine significantly higher when compared with all 
other groups, except for the group T3, to which a higher dose of 
tacrolimus was administered (p>0.05).
Histological and statistical analysis
There was no change suggestive of acute tubular 
necrosis (ATN). Likewise, no significant difference was evidenced 
between groups for arteriolar thrombosis, glomerular thrombosis 
and intimal edema (characteristics of acute vascular toxicity); 
interstitial fibrosis, arteriolopathy, glomerular sclerosis, tubular 
atrophy and glomerular hypertrophy (characteristics of chronic 
toxicity) and inflammatory infiltrate.
On the other hand, analyzing the cytoplasmic vacuolation 
of proximal tubules (Figure 3A), typical of acute tubular toxicity 
(ATT), we found a statistical difference between the group T3 
with the control group (p=0.003) and a trend towards significance 
compared to SHAM (p=0.056). MMF, when administered alone, 
showed the highest score for cytoplasmic vacuolation (score 
of 0.8) (Figure 4), with significant difference compared to the 
groups control and SHAM. In turn, the group MT1 presented no 
difference compared to the group SHAM (p=0.06) and the group 
MT2 showed a low score (0.20), quite similar to the groups SHAM 
(p=0.83) and control. 
Regarding the presence of hyaline casts, a statistical 
difference was observed between the group T3 and all other groups 
(p=0.01); only the rats of this group showed these histological 
changes (Figure 3B).
FIGURE 2 – Median and Standard Deviation of biochemical parameters 
analyzed. A. Serum levels of tacrolimus (ng/dl), control and SHAM 
groups did not show serum levels of this drug; B. Serum levels of urea; C. 
Serum levels of creatinine.
Creatinine measurements showed no statistically 
significant differences between the groups control, SHAM, T1 
and T2 with each other (Figure 2C). However, when creatinine 
values of the group T3 were compared to those of groups control, 
SHAM, T1 and T2, these differences were statistically significant. 
FIGURE 3 – Histological analysis. A. Cytoplasmic vacuolation (Masson 
trichrome staining, x40 Magnification). B. Hyaline casts (PAS staining, 
x100 Magnification).
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Discussion
New drugs have been developed and much has been 
studied on the best immunosuppressive regimen for renal 
transplantation. Achieving lower and lower rejection rates 
with different combinations of immunosuppressive drugs, the 
importance of safety and tolerability has become increasingly 
important, especially in relation to preservation of graft function 
and graft and patient survival5. Several Brazilian renal transplant 
services employ the combination of MMF and tacrolimus for 
immunosuppression, so the present experiment studied these 
drugs alone and in combination, and performed a stratification of 
their doses.
The ischemia-reperfusion injury model and the drug 
administration by gavage used in this experiment have already 
been described. Jain et al.1 studied the effects of tacrolimus and 
cyclosporine, submitted Wistar rats to clamping of the right 
kidney, associated with left nephrectomy and orally administered 
cyclosporine (10mg/kg/day) or tacrolimus (0-2mg/kg/day) through 
gavage. In the present study, we performed right nephrectomy and 
clamping of the left kidney because the vessels of the left renal 
hilum are longer, which facilitate clamping.
In this study, we used doses of tacrolimus between 0.1 
mg/kg and 10mg/kg in order to observe the effects of medication 
from a sub-dose until high doses. According to Shihab et al.9, 
high doses of tacrolimus (0.5-2.0 mg/kg/day) are required for 
transplantation in rodents to prevent graft rejection, and the toxic 
therapeutic ratio between efficacy and side effects appears to be 
similar to that of humans.
Researches in animal models have shown that the 
consequences of ischemia-reperfusion depend on the duration of 
the procedure. In humans, ischemia during partial nephrectomy is 
associated with increased rates of acute renal failure and chronic 
kidney disease, and the maximum tolerated time, respectively 
for hot and cold renal ischemia is 20 and 35 minutos10. However, 
there is no consensus in the literature about the maximum period 
of ischemia-reperfusion to prevent irreversible renal damage11. In 
this way, we chose an ischemia-reperfusion period of 20 minutes, 
because prolonged periods can result in very severe kidney damage 
and even cause early death of animals.
The score model calculated by the average degree of 
histological findings used in this experiment had already been 
described. Nielsen et al.12 conducted an experiment aimed at 
evaluating glomerular function and renal morphological changes 
in rats treated with cyclosporine and tacrolimus via gavage, 
and sirolimus intraperitoneally. The morphological analysis of 
kidneys on the basis of a semi-quantitative score system evaluated 
subcapsular fibrosis and tubular basophilia. The tubular basophilia 
varied discretely in the treatment groups, on the other hand, fibrosis 
scores showed minimal variance. Shihab et al.9 also applied the 
score system for histological analysis through an experimental 
model developed with rats subjected to low salt diet and treated 
with subcutaneous tacrolimus (1mg/kg/day) or to equivalent doses 
of placebo, killing the animals with seven or 28 days. Histological 
changes were examined by semi-quantitative score for each change 
(tubular injury, tubulointerstitial fibrosis and hyalinosis of afferent 
arterioles). Injuries typical of chronic nephrotoxicity caused by 
tacrolimus, such as interstitial fibrosis and arteriolopathy, were 
verified only at 28 days9.
With regard to histological changes, this study showed 
mild changes. Study time of 14 days may have been decisive for 
the lack of evidence of lesions typical of chronic nephrotoxicity, 
as was demonstrated by Shihab et al.9, in which these lesions 
were not apparent after seven days, but only after 28 days. In 
the same way, Nielsen et al.12, in the study period of 14 days 
showed minimal variance in the scores of fibrosis, as previously 
described. The most remarkable histological findings in this 
study were related to hyaline casts and cytoplasmic vacuolation 
of proximal tubules, characteristic of early nephrotoxicity. The 
first findings were evident only at high doses of tacrolimus. 
Cytoplasmic vacuolation was identified at higher scores in groups 
under high doses of tacrolimus and in the group in which MMF 
was used alone. The combination between MMF and tacrolimus 
at usual dose did not potentiate the vacuolation score, but, when 
combined with half the usual dose of tacrolimus, the score was 
FIGURE 4 – Cytoplasmic vacuolation score in the tested groups (mean 
± standard deviation).
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below, similar to the SHAM group and statistically lower than 
the groups T3 and M1. This result suggests a possible protective 
effect of the combination of drugs.
Several studies investigated the impact of the use 
of immunosuppressive drugs on renal function. Nielsen et 
al.12 registered that the use of cyclosporine, tacrolimus and 
sirolimus caused a significant decrease in creatinine clearance. 
In turn, Shihab et al.9 demonstrated that tacrolimus induced a 
significant increase in serum creatinine after 28 days of treatment. 
Considering the combination of drugs, prospective, randomized 
studies were carried out comparing immunosuppressive regimens 
on the basis of the use of tacrolimus combined with MMF and 
with sirolimus, and indicated that tacrolimus combined with 
MMF improves renal graft function and reduces cardiovascular 
risk, preventing and reducing the deterioration of graft function by 
chronic nephropathy13.
The present results demonstrated peculiar changes in renal 
function. The analysis of serum urea suggested a dose-dependent 
nephrotoxic effect of tacrolimus and a possible protective effect of 
this drug combined with MMF, corroborating previous studies13. 
On the other hand, high doses of tacrolimus significantly increased 
serum creatinine levels when compared with the control group and 
the SHAM group but lower doses did not cause significant changes. 
These results may be due to the fact that only the group T3 (mean 
= 2.35; SD = ± 0.67) presented serum levels of tacrolimus near the 
therapeutic range of the drug (5-15 ng/ml)14,15.
The reason for not having achieved therapeutic serum 
levels, even having been administered high doses of tacrolimus, 
seems to be related to the bioavailability of the drug. Oral 
administration of tacrolimus has low bioavailability9. Studies have 
found that subcutaneous administration may achieve serum levels 
of the therapeutic window for humans9. Besides that, these studies 
evidenced a high clearance of tacrolimus and higher volume of 
distribution in rats (2.0L/hr/kg and 20.2L/kg, respectively) in 
comparison with the pharmacokinetics in humans (0.1L/hr/kg and 
1L/Kg, respectively), suggesting the use of higher doses in rats to 
reach the same serum levels9.
In this study, groups using MMF or MMF combined with 
tacrolimus showed significantly higher serum creatinine compared 
with all other groups, except for the group T3, in which a higher 
dose of tacrolimus was used (p> 0.05). Such findings may result 
from a sub-dose of tacrolimus in the groups T1, T2, MT1 and 
MT2. As emphasized previously, only the group T3 presented 
serum levels of tacrolimus close to the therapeutic range of the 
drug. Another important issue is that the mean values of creatinine 
in groups M1, MT1 and MT2 were respectively 0.55, 0.59 and 
0.58, which were within normal reference standards of creatinine 
in rats (0.6 ± 0.02mg/dl)16.
Conclusions
Histologically, the association of injury by ischemia-
reperfusion with the use of tacrolimus or mycophenolate-mofetil 
alone demonstrated a higher rate of renal changes typical of 
early nephrotoxicity. In laboratory, the combination of injury by 
ischemia-reperfusion with tacrolimus at higher doses proved to be 
nephrotoxic.
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